166 patients with reticular pseudodrusen in one or both eyes manifestations of AMD at entry into study
| <10 Drusen | Smaller drusen <124 μm | Larger drusen* | Para-foveal pigment† | CNV | GA | Other‡ | |
| Study eye 166 | 7 (4.2%) | 42 (25.3%) | 82 (49.4%) | 20 (12.0%) | 11 (6.6%) | 4 (2.4%) | |
| Fellow eye 166 | 2 (1.2%) | 15 (9.0%) | 40 (24.1%) | 8 (4.8%) | 84 (50.1%) | 13 (7.8%) | 4 (2.4%) |
| Total 332 | 9 (2.7%) | 57 (17.2%) | 122 (36.8%) | 28 (8.4%) | 95 (28.6%) | 17 (5.1%) | 4 (1.2%) |
↵* Includes regressing drusen with focal hyperpigmentation.
↵† Hyperpigmentation distributed around foveal perimeter, not focally related to drusen.
↵‡ Other: retinal vein occlusion two eyes, dense cataract one eye, dense asteroid hyalosis one eye.
Note late AMD affects 112 eyes (34.8% of total).
AMD, age-related macular degeneration; CNV, choroidal neovascularisation; GA, geographic atrophy.